LECT2 and hepatocellular carcinoma: Results from another study indicated that LECT2 is a crucial role in liver tumorigenesis as its absence alters the tumor phenotype and the tumor microenvironment suggested that LECT2 is a promising immunotherapeutic option for HCC (29).